(Received for publication, July 15, 1929) Previous evidence (1) of immunological relationship between a variety of Saccharomyces cerevisiae and the Type II Pneumococcus consisted in the inter-reactions of the yeast and the bacteria in the antisera produced by immunization of rabbits with the two different microorganisms. This paper reports the active immunization of mice against Type II pneumococci by vaccination with yeast.
A group of mice were vaccinated with heated suspensions of yeast cells, and tested for active immunity by subsequent injection of viru-]ent Type II Pneumococcus. Because of the known (2) irregularity in the active ~mmunity responses of individual mice to homo]ogous vaccination with Type II pneumococci, it seemed best to base the imThunity tests of the yeast-vaccinated mice upon the percentage of animals surviving the test injection of a uniform dose of the Type II bacteria. In order to show that the protection afforded by vaccination with the yeast was not non-specific, groups of yeast-vaccinated mice were tested against comparable doses of Types I and III, as well as against Type II pneumococci.
~EXPERIM-~,NTAL
Methods: A group of 100 white mice of approximately the same age and weight were injected subcutaneously at 2 day intervals with 0.5 cc. of a 0.1 per cent. suspension of the dried yeast cells (boiled 5 minutes); after 12 subcutaneous injections and a rest of 3 days, two intraperitoneal injections were given. The active irnmuI~ty tests were made on the 92 surviving mice 12 days after the last immunization injection. 579
The yeast-vaccinated animals were divided into three groups: 57 to be tested against Type II pneumococci, 20 against Type I, and 15 against Type III pneumococci. A uniform dosage of 100 times the minimum required for death of normal mice was employed for the tests with the three types of pneumococci. The quantitative sufficiency of the test doses was controlled by injecting groups of normal mice with each culture. The test strains were highly virulent for mice; the cultures used were inoculated directly from the heart's blood of mice. The results are presented in Table I .
The results (Table I) showed that 20 of 57, or 34 per cent of the mice vaccinated with yeast were protected against subsequent infection with 100 lethal doses of virulent Type II pneumococci. The uniform deaths in the control group of non-vaccinated mice proved that the infection test dose was sufficient to eliminate any irregularities (2) . The uniform death of the yeast-vaccinated mice tested against Types I and III pneumococci is important evi-dence that the protection conferred by the yeast vaccination was specific to the Type II Pneumococcus.
COMME.NT
The described protection of mice indicates that these animals respond to yeast antigen with production of antibodies specifically reactive with Type II pneumococd. It had been shown (i) that rabbits can respond to the same yeast antigen with production of antibodies that agglutinate Type II bacterial cells, precipitate Type II culture filtrates, and confer passive protection against Type II infection; the more responsive rabbits yielding sera comparable in anti-Type II potency to the antisera produced by immunization with the Type II bacterial ceils themselves. In another study (3) it was found that the relative antigenic effectiveness of two related strains of pneumococd differed in different species of animals. The present report therefore, is of interest as evidence that the immunological relationship between the yeast and Type II pneumococci causes mice, as well as rabbits, to respond to yeast antigen with production of antibodies specifically reactive with the Type II variety of Pneumococcus.
S~ARY
Mice vaccinated with yeast were protected against subsequent infection with Type II pneumococci, but not against Types I or III. While the protection was not universal, as high a percentage of mice acquired active anti-Type II immunity, as was obtained by vaccination of another group of mice with Type II pneumococci themselves. This specific protection of mice by active immunization with the yeast antigen, is probably due to the same immunological relationship responsible for the anti-Type II reactivity of the antisera of rabbits immunized with yeast antigen.
